Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment

CompletedOBSERVATIONAL
Enrollment

65

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

October 1, 2024

Study Completion Date

October 1, 2024

Conditions
Opioid Abuse
Interventions
BEHAVIORAL

Implementation of the BINDeR-Tx service model

ED-initiated buprenorphine, discharge with naloxone, and warm-hand off referral for continued treatment for individuals with OUD. This is considered standard treatment at the University of Utah ED. In order to extend these services to rural hospitals this study will be assisting Castleview Hospital to establish a similar program.

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

Jerry Cochran

OTHER